Access to medicines as a human right : implications for pharmaceutical industry responsibility /
Saved in:
Imprint: | Toronto : University of Toronto Press, c2012. |
---|---|
Description: | vi, 214 p. ; 24 cm |
Language: | English |
Subject: | |
Format: | E-Resource Print Book |
URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/9327741 |
Table of Contents:
- Acknowledgments
- 1. Introduction: Access to Medicines as a Human Right - What Does It Mean for Pharmaceutical Industry Responsibilities?
- Part 1. Rights, Norms, and Ethics
- 2. Human Rights Responsibilities of Pharmaceutical Companies in Relation to Access to Medicines
- 3. Improving Access to Essential Medicines: International Law and Normative Change
- 4. Corporate Social Responsibility and the Right to Essential Medicines
- Part 2. Social Versus Business Responsibilities
- 5. Benchmarking and Transparency: Incentives for the Pharmaceutical Industry's Corporate Social Responsibility
- 6. Social Responsibility and Marketing of Drugs in Developing Countries: A Goal or an Oxymoron?
- Part 3. Case Studies for Achieving Corporate Responsibility
- 7. Managing the Market for Medicines Access: Realizing the Right to Health by Facilitating Compulsory Licensing of Pharmaceuticals - A Case Study of Legislation and the Need for Reform
- 8. Ubuntu, AIDS, and the King II Report: Reflections on Corporate Social Responsibility in South Africa
- Annex: Human Rights Guidelines for Pharmaceutical Companies in Relation to Access to Medicines
- Contributors